Stock_Titan Posted - 3 days ago

$VCYT Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024 https://www.stocktitan.net/news/VCYT/veracyte-to-release-first-quarter-2024-financial-results-on-may-7-pqvjh9wk1cir.html

DonCorleone77 Posted - 3 days ago

$VCYT Veracyte study shows Decipher Prostate Test is prognostic Veracyte announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance AS for prostate cancer, the Decipher Prostate Genomic Classifier is prognostic for identifying those whose disease is likely to progress. The findings make the Decipher test the only gene expression test to have treatment-outcome data from a prospective, multi-center, phase 2, randomized trial in the AS population. Patients whose prostate cancer is found at an early stage and who are clinically low or intermediate risk are commonly offered AS, meaning they are closely monitored rather than undergo intervention such as surgery or radiation. Identifying the optimal candidates for active surveillance, however, is not always easy, as clinical indicators are limited in their ability to identify those who may be at a higher risk of future grade reclassification or cancer progression. "The findings from the ENACT trial analysis demonstrate that the Decipher Prostate test is a predictor of disease progression on AS," said Elai Davicioni, Ph.D., Veracyte's medical director for Urology. "These data also further reinforce Veracyte's commitment to evidence generation that supports the Decipher Prostate test's 'Level 1B' evidence status - the highest among commercially available gene expression tests - in the most recent NCCN Guidelines* for prostate cancer."

Stock_Titan Posted - 3 days ago

$VCYT New Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance https://www.stocktitan.net/news/VCYT/new-study-shows-veracyte-s-decipher-prostate-test-is-prognostic-for-8jb16ihkx57r.html

Doorkey Posted - 4 days ago

$VCYT Adding on my swing list.

Stock_Titan Posted - 1 week ago

$VCYT Veracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024 https://www.stocktitan.net/news/VCYT/veracyte-announces-that-nine-studies-reinforcing-the-value-of-nb9mbpar89j2.html

Aigner_Andreas Posted - 1 month ago

#DeathCross $VCYT at 22.07 R7 HiLo 23% T1Y 30 buy 2.0 DIV N/A #Veracyte I #stocks #trading #finance #market

Stock_Titan Posted - 02/27/24

$VCYT Veracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines https://www.stocktitan.net/news/VCYT/veracyte-s-decipher-prostate-test-receives-highest-evidence-level-g5rqr760yrwh.html

Thestocktraderhubzee Posted - 02/27/24

WATCHLIST FEB 27 2024… $MIST HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target $ZS Morgan Stanley Maintains Equal-Weight on Zscaler, Raises Price Target to $214 $VCYT Morgan Stanley Maintains Underweight on Veracyte, Lowers Price Target to $21 $NRIX Morgan Stanley Maintains Equal-Weight on Nurix Therapeutics, Raises Price Target to $10 $EQR Morgan Stanley Maintains Equal-Weight on Equity Residential, Raises Price Target to $64

TickerDD_com Posted - 02/26/24

From 2/16/2024, looking back across 22 Month-Ends for VCYT, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $VCYT #VCYT #VCYTStock #TickerDD #VCYTPrice https://www.youtube.com/watch?v=JjvC2HxSM_A

Following_the_trend Posted - 2 months ago

$VCYT Bot

epsguid Posted - 2 months ago

$VCYT reported a loss of $0.04, consensus was ($0.07) via @eWhispers #epsbeat http://eps.sh/d/vcyt

Stock_Titan Posted - 2 months ago

$VCYT Veracyte Announces Fourth Quarter and Full-Year 2023 Financial Results https://www.stocktitan.net/news/VCYT/veracyte-announces-fourth-quarter-and-full-year-2023-financial-e0h2jf3yv6jj.html

Stock_Titan Posted - 2 months ago

$VCYT Veracyte to Participate in the Raymond James 45th Annual Institutional Investors Conference https://www.stocktitan.net/news/VCYT/veracyte-to-participate-in-the-raymond-james-45th-annual-jxlylg846if0.html

Stock_Titan Posted - 2 months ago

$VCYT Veracyte to Release Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 https://www.stocktitan.net/news/VCYT/veracyte-to-release-fourth-quarter-and-full-year-2023-financial-wvpll36uyusy.html

DavidEather Posted - 2 months ago

$BTAI $CRNC $VCYT Analyst price target for today}[ https://live-alerts-stock-trades.topmarketwatch.vip

Stock_Titan Posted - 2 months ago

$VCYT Veracyte Completes Acquisition of C2i Genomics https://www.stocktitan.net/news/VCYT/veracyte-completes-acquisition-of-c2i-38kp60vfvarg.html

cctranscripts Posted - 3 months ago

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12883475 $VCYT

RiskVsReward Posted - 3 months ago

$VCYT Keep this on your watch lists okay. 📢

EarningsInsider Posted - 3 months ago

Veracyte Sees Short Interest Decrease from 3,240,000 shares to 2,510,000 shares. $VCYT https://www.marketbeat.com/stocks/NASDAQ/VCYT/short-

tickeron Posted - 3 months ago

Does this make you nervous? $VCYT entered Uptrend as Momentum indicator ascends above 0 level. View odds of downtrend. https://srnk.us/go/4964263

dividendinvestorbyeagle Posted - 3 months ago

$VCYT close increased > 10% (Veracyte Inc) https://www.dividendinvestor.com/dividend-news/?symbol=vcyt http://dlvr.it/T18GbV

StockAutomatePro Posted - 3 months ago

$VCYT Not a bad time to buy chart analysis shows potential growth. We alerted the BUY signal at $26.1 and we were able to close this one with profit at $29.1 ✅

UltraAlgo Posted - 3 months ago

$VCYT Sell Rating based off 5 signals, 15-min chart. 💸 UltraAlgo.com https://i.redd.it/tepu12h6t9bc1.png

EarningsInsider Posted - 3 months ago

$VCYT updates FY 2024 guidance to EPS and revenue guidance to $394.0 million-$402.0 million. www.marketbeat.com/stocks/NASDAQ/VCYT/earnings

EarningsInsider Posted - 3 months ago

$VCYT updates FY 2023 guidance to EPS and revenue guidance to $358.0 million-$359.0 million. www.marketbeat.com/stocks/NASDAQ/VCYT/earnings

EarningsInsider Posted - 3 months ago

$VCYT updates Q4 2023 guidance to EPS and revenue guidance to $95.0 million-$96.0 million. www.marketbeat.com/stocks/NASDAQ/VCYT/earnings/

Stock432 Posted - 3 months ago

$PSNL new valuation datapoint today. C2i, a MRD technology company, sold to $VCYT for 95M. Not great, but from what I understand, this technology isn’t nearly as sensitive as next personal. Remember that haystack, claiming similar specs to next personal, sold to quest for $400M lol. In any case, current psnl market cap is 108M and has so many other things other than MRD going for it.

Last10K Posted - 3 months ago

$VCYT just filed with the SEC a Earnings Release, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/VCYT/0001193125-24-003949.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=VCYT

cctranscripts Posted - 3 months ago

Veracyte Announces Preliminary Full-Year 2023 Results, https://www.conferencecalltranscripts.org/summary/?id=12849255 $VCYT

risenhoover Posted - 3 months ago

$VCYT / Veracyte files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2024 VERACYTE, INC. (E https://fintel.io/doc/sec-veracyte-inc-1384101-8k-2024-january-08-19730-495?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing